Page last updated: 2024-10-31

entinostat and Central Nervous System Neoplasm

entinostat has been researched along with Central Nervous System Neoplasm in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Glioblastoma is the most common primary brain tumor with a dismal prognosis, highlighting the need for novel treatment strategies."1.37Chemosensitization of glioblastoma cells by the histone deacetylase inhibitor MS275. ( Bangert, A; Cristofanon, S; Debatin, KM; Fulda, S; Häcker, S, 2011)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bangert, A1
Häcker, S1
Cristofanon, S1
Debatin, KM1
Fulda, S1
Knipstein, JA1
Birks, DK1
Donson, AM1
Alimova, I1
Foreman, NK1
Vibhakar, R1

Other Studies

2 other studies available for entinostat and Central Nervous System Neoplasm

ArticleYear
Chemosensitization of glioblastoma cells by the histone deacetylase inhibitor MS275.
    Anti-cancer drugs, 2011, Volume: 22, Issue:6

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplasti

2011
Histone deacetylase inhibition decreases proliferation and potentiates the effect of ionizing radiation in atypical teratoid/rhabdoid tumor cells.
    Neuro-oncology, 2012, Volume: 14, Issue:2

    Topics: Acetylation; Apoptosis; Benzamides; Cell Line, Tumor; Central Nervous System Neoplasms; Combined Mod

2012